COMMODORE CAPITAL LP

Holdings History for Celldex Therapeutics, Inc. - Common Stock, par value $.001 (CLDX)

Symbol: CLDX on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, par value $.001
Latest Disclosed Ownership: 3.35M shares
Security Ownership: 5%

Shares, Excluding Options vs Price

Value, Excluding Options

COMMODORE CAPITAL LP ownership in Celldex Therapeutics, Inc. Common Stock, par value $.001 (CLDX)

2025-04-10 - COMMODORE CAPITAL LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.35M shares of Celldex Therapeutics, Inc. Common Stock, par value $.001 (CLDX). This represents 5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
COMMODORE CAPITAL LP	5%		$60.8M	3.35M			$18.15	13G	4/3/2025	10 Apr 2025 16:05:05

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024		-3.44%	$0	0	-1,618,937	-100%		Q4 2024
9/30/2024	3.44%	+0.41%	$55M	1.62M	+193,937	+13.6%	$33.99	Q3 2024
6/30/2024	3.6%	+1.41%	$52.7M	1.43M	+558,532	+64.5%	$37.01	Q2 2024
3/31/2024	2.43%	+0.6%	$36.4M	866K	+164,501	+23.4%	$41.97	Q1 2024
12/31/2023	2.43%	-0.02%	$27.8M	702K	-4,698	-0.66%	$39.66	Q4 2023
9/30/2023	2.27%	+0.25%	$19.4M	707K	+75,000	+11.9%	$27.52	Q3 2023
6/30/2023	2.41%	+0.52%	$21.4M	632K	+135,842	+27.4%	$33.93	Q2 2023
3/31/2023	2.72%		$17.8M	496K			$35.98	Q1 2023
12/31/2022	3.33%	-0.29%	$22.1M	496K	-42,989	-7.98%	$44.57	Q4 2022
9/30/2022	2.52%		$15.1M	539K			$28.11	Q3 2022
6/30/2022	3.07%	+1.7%	$14.5M	539K	+297,613	+123%	$26.96	Q2 2022
3/31/2022	1.83%	+1.83%	$8.22M	241K	+241,199	NEW	$34.06	Q1 2022
12/31/2021		-3.67%	$0	0	-248,207	-100%		Q4 2021
9/30/2021	3.53%	-1.42%	$13.4M	248K	-75,230	-23.3%	$53.99	Q3 2021
6/30/2021	3.77%	-0.62%	$10.8M	323K	-46,514	-12.6%	$33.44	Q2 2021
3/31/2021	3.04%	+0.15%	$7.62M	370K	+13,520	+3.79%	$20.60	Q1 2021
12/31/2020	3.4%		$6.25M	356K			$17.52	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.